SUNWELS Co.,Ltd. (9229) AI Stock Analysis

• Market Cap: ¥17.19B
• Dividend Yield: N/A
• Average Volume (3M): 115.88K
• Price to Earnings (P/E): ―
• Beta (1Y): 1.04
• Revenue Growth: 10.09%
• EPS Growth: -340.83%
• Country: JP
• Employees: 2,435
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Care Facilities
• EPS (TTM): -24.42
• Shares Outstanding: 35,220,000
• 10 Day Avg. Volume: 157,720
• 30 Day Avg. Volume: 115,876
• PEG Ratio: 0.09
• Price to Book (P/B): 2.13
• Price to Sales (P/S): 0.69
• P/FCF Ratio: -7.88
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Hold
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 47 Neutral
• Price Target: ¥399.00 ▲(6.40% Upside)

The overall stock score is primarily impacted by financial performance challenges, including high leverage and negative net income. Technical analysis indicates bearish momentum, further weighing down the score. Valuation concerns, particularly the negative P/E ratio, also contribute significantly to the low score.

Positive Factors

Revenue Growth

Consistent revenue growth indicates robust demand for SUNWELS' solar energy solutions, supporting long-term market expansion and business sustainability.

Market Position

SUNWELS' leadership in renewable energy and focus on innovative solar solutions position it well to capitalize on the growing demand for clean energy.

Strategic Partnerships

Collaborations enhance SUNWELS' ability to participate in large-scale projects, benefiting from subsidies and incentives, and strengthening its market presence.

Negative Factors

High Leverage

High leverage increases financial risk and limits flexibility, potentially impacting SUNWELS' ability to invest in growth and weather economic downturns.

Profitability Challenges

Ongoing profitability issues, as seen in negative margins, suggest operational inefficiencies that could hinder long-term financial health and competitiveness.

Cash Flow Management

Negative free cash flow indicates challenges in cash management, which could constrain SUNWELS' ability to fund operations and strategic initiatives.

SUNWELS Co.,Ltd. Business Overview & Revenue Model

Company Description

SUNWELS Co., Ltd. (9229) is a leading company in the renewable energy sector, specializing in the development and manufacturing of solar energy solutions and related technologies. The company focuses on providing innovative products and services that enhance energy efficiency and sustainability, catering to both residential and commercial markets. SUNWELS is committed to advancing clean energy initiatives, contributing to a greener future through its cutting-edge solar panels, energy storage systems, and integrated energy management solutions.

How the Company Makes Money

SUNWELS Co., Ltd. generates revenue primarily through the sale of solar energy products, including photovoltaic panels and energy storage systems. The company also earns income from the installation services it provides to clients, ensuring that customers receive a complete solution for their energy needs. In addition to product sales, SUNWELS may engage in long-term service agreements and maintenance contracts, which provide a steady stream of recurring revenue. Strategic partnerships with other energy companies and government entities for renewable energy projects further bolster its financial performance, allowing SUNWELS to participate in larger-scale initiatives and benefit from subsidies or incentives related to clean energy development.

SUNWELS Co.,Ltd. Financial Statement Overview

Summary

SUNWELS Co.,Ltd. demonstrates strong revenue growth but faces profitability and cash flow challenges. High leverage and negative net income in 2025 are key concerns. The company needs to focus on improving operational efficiency and managing debt levels to enhance financial stability.

Income Statement

SUNWELS Co.,Ltd. has shown significant revenue growth over the years, with a notable increase from 2020 to 2025. However, the company is facing challenges in profitability, as indicated by a negative net profit margin in 2025. The gross profit margin has decreased over time, and the EBIT and EBITDA margins have also shown volatility, reflecting operational inefficiencies.

Balance Sheet

The company has a high debt-to-equity ratio, indicating significant leverage, which poses a risk. The return on equity has been inconsistent, with a negative ROE in 2025 due to negative net income. The equity ratio has improved over the years, suggesting a gradual strengthening of the equity base relative to total assets.

Cash Flow

SUNWELS Co.,Ltd. has experienced fluctuations in free cash flow, with negative free cash flow in recent years, highlighting cash management challenges. The operating cash flow to net income ratio is strong, indicating good cash generation relative to reported earnings. However, the free cash flow to net income ratio is concerning due to negative free cash flow.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	26.46B	26.50B	21.36B	13.72B	8.42B	5.40B
Gross Profit	3.59B	4.92B	6.42B	3.75B	2.11B	1.38B
EBITDA	1.84B	1.88B	4.35B	1.45B	819.00M	559.72M
Net Income	-2.17B	-925.00M	802.00M	303.00M	255.71M	241.42M
Balance Sheet
Total Assets	42.22B	38.99B	31.52B	19.21B	9.02B	4.79B
Cash, Cash Equivalents and Short-Term Investments	3.62B	5.64B	3.31B	2.61B	814.76M	496.36M
Total Debt	26.64B	22.49B	20.11B	11.20B	6.60B	3.03B
Total Liabilities	34.32B	30.37B	24.38B	13.84B	8.15B	4.09B
Stockholders Equity	7.89B	8.62B	7.14B	4.61B	864.74M	693.47M
Cash Flow
Free Cash Flow	0.00	-2.32B	-2.94B	-741.00M	-78.18M	-392.99M
Operating Cash Flow	0.00	1.88B	2.56B	1.14B	378.19M	201.03M
Investing Cash Flow	0.00	-4.40B	-5.66B	-2.04B	-633.05M	-648.06M
Financing Cash Flow	0.00	4.84B	3.80B	2.70B	573.26M	489.42M

SUNWELS Co.,Ltd. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 375.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Positive
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:9229, the sentiment is Negative. The current price of 375 is below the 20-day moving average (MA) of 458.30, below the 50-day MA of 536.30, and below the 200-day MA of 613.85, indicating a bearish trend. The MACD of -41.97 indicates Positive momentum. The RSI at 22.00 is Positive, neither overbought nor oversold. The STOCH value of 2.60 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:9229.

SUNWELS Co.,Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
2374	75 Outperform	¥30.43B	17.23	―	2.47%	3.88%	0.31%
7061	70 Neutral	¥11.42B	21.15	―	1.20%	18.03%	-11.68%
6059	69 Neutral	¥6.84B	3.12	―	2.72%	1.26%	562.09%
6557	65 Neutral	¥9.42B	19.28	―	―	14.05%	-12.70%
7133	64 Neutral	¥9.13B	12.98	―	1.90%	18.58%	-6.30%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
9229	47 Neutral	¥17.19B	-8.93	―	―	10.09%	-340.83%

SUNWELS Co.,Ltd. Corporate Events

SUNWELS Co., Ltd. Advances in Recurrence Prevention Measures for Home Nursing Services

SUNWELS Co., Ltd. has made significant progress in implementing recurrence prevention measures to enhance its home health care nursing business. This includes establishing a Risk Review Committee, conducting regular management facility rounds, and strengthening internal controls through electronic record systems and collaborative nursing plan reviews. These efforts aim to improve compliance, reduce operational burdens, and ensure accurate service delivery, ultimately enhancing the company’s operational efficiency and stakeholder trust.

SUNWELS Co., Ltd. Revises Financial Forecasts Amid Staff Turnover Challenges

SUNWELS Co., Ltd. has revised its financial forecasts for the fiscal year ending March 31, 2026, due to increased staff turnover at certain facilities, which has limited their ability to accept new residents. This has led to lower than expected net sales and profits, prompting the company to adjust its earnings projections downward.

Sunwels Co., Ltd. Reports Q2 FY2026 Financial Highlights and Strategic Initiatives

Sunwels Co., Ltd. has released its financial highlights for the second quarter of FY March 2026, emphasizing its commitment to societal challenges in healthcare and caregiving. The company is working towards establishing specialized facilities to support Parkinson’s disease patients, which aligns with its goal of realizing a sustainable society. This initiative is expected to enhance Sunwels’ positioning in the healthcare sector and potentially impact its stakeholders positively.

SUNWELS Co., Ltd. Reports Challenging Financial Results for H1 2025

SUNWELS Co., Ltd. reported a challenging financial performance for the six months ended September 30, 2025, with a net loss and decreased operating profit compared to the previous year. The company’s financial position weakened, with a decline in net assets and equity ratio, and no dividends were declared, indicating potential concerns for stakeholders.